Dynavax Technologies Corp (NASDAQ: DVAX) suffers from significant negative changes in fundamentals. Negative developments: the stock’s power rating fell below 50, significant quarterly earnings deceleration occurred, the consensus estimate for December, 2025 decreased significantly, and significant quarterly sales deceleration occurred. Positive development: the consensus estimate for December, 2024 increased significantly.
Recent notable negative changes in investment behavior have affected Dynavax Technologies Corp (NASDAQ: DVAX): negative upside/downside volume developed.
In light of these highly negative signals we are reviewing our current Overall Rating of F. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
DVAX’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a modest Value Builder.
Dynavax Technologies has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Dynavax Technologies has a slightly negative Power Rating of 31 and a slightly negative Appreciation Score of 30, producing the Lowest Value Trend Rating.
Recent Price Action
Dynavax Technologies Corp (NASDAQ: DVAX) stock closed at $13.14 on 3/8/24 after a large increase of 2.5%. However, below average trading volume at 72% of normal accompanied the advance. The stock has risen 3.7% during the last week and has performed in line with the market over the last nine months.
Be the first to comment